RARE VENTURES
Live / Applied — Non-final action mailed (as of 06 Oct 2026)
Now
Refused for now — an office action was mailed 06 Oct 2026.
A response is due by 06 Jan 2027; with no response the application is abandoned.
What this means for you
Not registered yet, but its 01 Jul 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99916476
- Mark type
- Word mark
- Filed
- 01 Jul 2026
- Attorney of record
- Wei Yu
Goods and services
- Class 035 — Advertising and business services: Business management and business administration services; Business consulting and advisory services; Promoting the interests of medical and scientific research organizations; Business incubation and acceleration services, namely, providing business development, mentoring, and administrative support to companies and research ventures in the rare disease and life sciences sectors; Business consulting and management services for biotechnology startups and research organizations focused on rare disease therapeutics; Administration of grant programs, including reviewing applications and managing the disbursement and oversight of research funding.
- Class 036 — Insurance and financial services: Charitable services, namely, providing financial support to medical and scientific research programs; Charitable fundraising services; Providing grants for scientific and medical research; Charitable services, namely, providing funding and financial grants for research into rare and orphan diseases; Charitable fundraising services to support the research, diagnosis, and treatment of rare diseases; Providing financial grant and funding to research projects, investigators, and biotech ventures focused on rare disease therapies; Financial sponsorship of scientific research, clinical studies, and translational research programs in the field of rare and orphan diseases.
- Class 041 — Education and entertainment services: Educational services in the field of medicine and science; Arranging and conducting educational conferences; Providing information in the field of health and medical research; Educational services, namely, organizing and conducting conferences, workshops, and symposia in the field of rare disease research and treatment; Providing online educational resources, publications, and information regarding rare and orphan diseases; Promoting public awareness of rare diseases and the need for research and treatment; Training and mentoring programs for researchers and biotech entrepreneurs in the field of rare disease drug development.
Owner
- EB Research Partnership Inc., New York, NY, US
Prosecution history
- 06 Oct 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Oct 2026 — NON-FINAL ACTION E-MAILED
- 06 Oct 2026 — NON-FINAL ACTION WRITTEN
- 01 Oct 2026 — ASSIGNED TO EXAMINER
- 01 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 01 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Jul 2026 — NEW APPLICATION ENTERED